Answers are grounded in this paper and cite their sources.
Introduction: Dialysis therapy imposes a substantial economic burden, and data on per-patient medical costs between hemodialysis (HD) and peritoneal dialysis (PD) in Japan based on large-scale databases are limited. Methods: This retrospective cohort study used the JMDC medical institution database (April 2014 to December 2025). Patients with continuous monthly dialysis records for 24 months (n = 1922; HD: 1137, PD: 785) and 60 months (n = 239) were included. Per-patient medical costs were compared between the HD and PD groups. Results: In patients with 24-month dialysis records, monthly medical costs (mean ± SD) were 441,421 ± 136,209 JPY for the HD-only group and 378,038 ± 157,118 JPY for the PD-only group. Year 2 medical costs were 4,992,931 ± 1,718,757 JPY and 4,078,469 ± 2,009,366 JPY, respectively, with PD costs being approximately 18% lower than HD. Among PD patients, those in the non-APD group had lower monthly costs (319,731 JPY) compared with those who used APD for all 24 months (451,702 JPY). Conclusions: Per-patient medical costs for PD patients in Japan were lower than for HD patients. These findings show lower per-patient medical costs associated with PD and complement macro-level analyses using national databases.
No takes yet. Share an insight, caveat, or question.
Takami et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: